Tag: Meiji Seika Pharma

Tokyo-based Meiji Seika Pharma has received approval in Japan to produce the world’s first self-amplifying mRNA COVID-19 vaccine without safety data. The world's first COVID-19 self-amplifying mRNA (sa-mRNA) vaccine...